OptiNose, Inc. (OPTN)

USD 9.4

(0.11%)

Total Liabilities Summary of OptiNose, Inc.

  • OptiNose, Inc.'s latest annual total liabilities in 2023 was 194.33 Million USD , down -3.24% from previous year.
  • OptiNose, Inc.'s latest quarterly total liabilities in 2024 Q2 was 174.72 Million USD , down -4.48% from previous quarter.
  • OptiNose, Inc. reported annual total liabilities of 200.84 Million USD in 2022, up 6.92% from previous year.
  • OptiNose, Inc. reported annual total liabilities of 187.84 Million USD in 2021, up 3.2% from previous year.
  • OptiNose, Inc. reported quarterly total liabilities of 182.92 Million USD for 2024 Q1, down -5.87% from previous quarter.
  • OptiNose, Inc. reported quarterly total liabilities of 194.33 Million USD for 2023 Q4, up 8.55% from previous quarter.

Annual Total Liabilities Chart of OptiNose, Inc. (2023 - 2015)

Historical Annual Total Liabilities of OptiNose, Inc. (2023 - 2015)

Year Total Liabilities Total Liabilities Growth
2023 194.33 Million USD -3.24%
2022 200.84 Million USD 6.92%
2021 187.84 Million USD 3.2%
2020 182.02 Million USD 63.89%
2019 111.06 Million USD 12.9%
2018 98.37 Million USD 13.55%
2017 86.64 Million USD 90.88%
2016 45.38 Million USD 5.17%
2015 43.15 Million USD 0.0%

Peer Total Liabilities Comparison of OptiNose, Inc.

Name Total Liabilities Total Liabilities Difference
Esperion Therapeutics, Inc. 660.79 Million USD 70.591%
Theratechnologies Inc. 98.63 Million USD -97.016%
Safety Shot Inc 3.89 Million USD -4893.135%
Cosmos Health Inc. 30.25 Million USD -542.376%
Cronos Group Inc. 43.73 Million USD -344.336%
Ironwood Pharmaceuticals, Inc. 817.36 Million USD 76.224%
Kala Pharmaceuticals, Inc. 48.44 Million USD -301.146%
Organogenesis Holdings Inc. 181.36 Million USD -7.153%
Universe Pharmaceuticals INC 13.75 Million USD -1312.9%
ProPhase Labs, Inc. 42.54 Million USD -356.786%
Sonoma Pharmaceuticals, Inc. 8.75 Million USD -2119.45%
Dynavax Technologies Corporation 375.02 Million USD 48.181%
Radius Health, Inc. 804.29 Million USD 75.838%
China SXT Pharmaceuticals, Inc. 9.19 Million USD -2013.115%
Alvotech 1.88 Billion USD 89.677%
Sunshine Biopharma, Inc. 6.13 Million USD -3065.271%
Alpha Teknova, Inc. 38.55 Million USD -404.098%
Intra-Cellular Therapies, Inc. 136.87 Million USD -41.984%
SCYNEXIS, Inc. 55.45 Million USD -250.469%
Harrow Health, Inc. 241.75 Million USD 19.614%
Biofrontera Inc. 23.13 Million USD -739.859%
DURECT Corporation 30.4 Million USD -539.134%
Supernus Pharmaceuticals, Inc. 487.46 Million USD 60.133%
ANI Pharmaceuticals, Inc. 471.67 Million USD 58.799%
RedHill Biopharma Ltd. 20.97 Million USD -826.37%
Aquestive Therapeutics, Inc. 163.9 Million USD -18.566%
Cumberland Pharmaceuticals Inc. 52.51 Million USD -270.048%
SIGA Technologies, Inc. 57.97 Million USD -235.192%
Lifecore Biomedical, Inc. 219.8 Million USD 11.586%
Shineco, Inc. 47.6 Million USD -308.252%
Phibro Animal Health Corporation 725.54 Million USD 73.215%
Procaps Group S.A. 462.06 Million USD 57.942%
TherapeuticsMD, Inc. 14.02 Million USD -1285.929%
Regencell Bioscience Holdings Limited 219.51 Thousand USD -88430.468%
Viatris Inc. 27.21 Billion USD 99.286%
Sunshine Biopharma, Inc. 6.13 Million USD -3065.271%
Rockwell Medical, Inc. 30.88 Million USD -529.282%
Incannex Healthcare Limited 5.83 Million USD -3233.362%
Aytu BioPharma, Inc. 90.37 Million USD -115.022%
Tilray Brands, Inc. 892.11 Million USD 78.216%
Collegium Pharmaceutical, Inc. 947.87 Million USD 79.498%
PetIQ, Inc. 645.22 Million USD 69.881%
Silver Spike Investment Corp. 3 Million USD -6356.675%
Neurocrine Biosciences, Inc. 1.01 Billion USD 80.936%
Journey Medical Corporation 56.49 Million USD -243.962%
Alimera Sciences, Inc. 107.35 Million USD -81.023%
Petros Pharmaceuticals, Inc. 21.31 Million USD -811.696%
Assertio Holdings, Inc. 148.41 Million USD -30.939%
Shuttle Pharmaceuticals Holdings, Inc. 1.89 Million USD -10149.925%
Embecta Corp. 2.03 Billion USD 90.456%
Cyclo Therapeutics, Inc. 8.49 Million USD -2188.844%
Procaps Group, S.A. 462.06 Million USD 57.942%
PainReform Ltd. 2.69 Million USD -7121.665%
Avadel Pharmaceuticals plc 173.38 Million USD -12.082%
Hempacco Co., Inc. 18.82 Million USD -932.466%
Talphera, Inc. 6.29 Million USD -2989.587%
Pacira BioSciences, Inc. 704.25 Million USD 72.406%
Alvotech 1.88 Billion USD 89.677%
Lantheus Holdings, Inc. 835.25 Million USD 76.734%
Kamada Ltd. 109.96 Million USD -76.719%
Indivior PLC 1.95 Billion USD 90.04%
Currenc Group, Inc. 177.67 Million USD -9.376%
Evoke Pharma, Inc. 9.64 Million USD -1914.234%
Flora Growth Corp. 17.22 Million USD -1028.411%
Cyclo Therapeutics, Inc. 8.49 Million USD -2188.844%
Evolus, Inc. 209.68 Million USD 7.321%
HUTCHMED (China) Limited 536.38 Million USD 63.77%
Amphastar Pharmaceuticals, Inc. 873.49 Million USD 77.752%
Akanda Corp. 12.66 Million USD -1433.955%